Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Astra presents data on novel series of cPLA2 inhibitors

Sep. 9, 1998

Enbrel efficacy demonstrated in juvenile RA patients

Sep. 7, 1998

MDX-CD4 development progresses, triggering milestone payment from Eisai

Sep. 7, 1998

Substituted pyrimidines from Amgen inhibit cytokine production

Sep. 7, 1998

Antiadhesion agents prepared and evaluated at Hoechst

Sep. 7, 1998

MMP inhibitors in early development at British Biotech

Sep. 7, 1998

Dual 5-LO and COX-2 inhibitors for inflammatory disorders

Sep. 3, 1998

Zeneca patents new peptides for autoimmune/inflammatory disorders

Sep. 2, 1998

New treatment for osteoarthritis pain now available in the U.K.

Aug. 31, 1998

New agent for the prevention of osteoarthritis identified at Roche Bioscience

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...